4051 - 4075 of 6284 Results
Title
Year
-
OPENTitle: Orthogonal analysis of mitochondrial function in Parkinson’s disease patientsJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 15Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-024-06617-6Best OA location URL: https://doi.org/10.1038/s41419-024-06617-6Citation Count: 8
- Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study2019OPENTitle: Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 71End Page: 80Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30319-9Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133485Citation Count: 123
- Polysomnographic (PSG) Characteristics of Sleep Behaviour in Parkinson's Disease: A Brief Report2025OPENTitle: Polysomnographic (PSG) Characteristics of Sleep Behaviour in Parkinson's Disease: A Brief ReportJournal Name: Journal of Sleep ResearchPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/jsr.70108Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jsr.70108Citation Count: 0
- Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trial2024OPENTitle: Determination of optimal vibration dose to treat Parkinson's disease gait symptoms: A clinical trialJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 10Issue #:Start Page: 100248End Page: 100248Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100248Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100248Citation Count: 0
- Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson’s disease clinical trial2025OPENTitle: Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson’s disease clinical trialJournal Name: Stem Cell Research & TherapyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13287-025-04577-yBest OA location URL: https://stemcellres.biomedcentral.com/counter/pdf/10.1186/s13287-025-04577-yCitation Count: 0
-
OPENTitle: Estimation of genetic risk function with covariates in the presence of missing genotypesJournal Name: Statistics in MedicinePublisher: WileyVol: 36Issue #: 22Start Page: 3533End Page: 3546Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/sim.7376Best OA location URL: https://arxiv.org/pdf/1705.09591Citation Count: 4
- Exploring the layers of fatigue in Parkinson’s Disease: A comprehensive analysis of its prevalence and contributing factors2024OPENTitle: Exploring the layers of fatigue in Parkinson’s Disease: A comprehensive analysis of its prevalence and contributing factorsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 11Issue #:Start Page: 100288End Page: 100288Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2024.100288Best OA location URL: https://doi.org/10.1016/j.prdoa.2024.100288Citation Count: 1
- Evidence‐based standardized sample handling protocol for accurate blood‐based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization Consortium2025OPENTitle: Evidence‐based standardized sample handling protocol for accurate blood‐based Alzheimer's disease biomarker measurement: Results and consensus of the Global Biomarker Standardization ConsortiumJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.70752Best OA location URL: https://doi.org/10.1002/alz.70752Citation Count: 0
- An interpretable machine learning‐based cerebrospinal fluid proteomics clock for predicting age reveals novel insights into brain aging2024OPENTitle: An interpretable machine learning‐based cerebrospinal fluid proteomics clock for predicting age reveals novel insights into brain agingJournal Name: Aging CellPublisher: WileyVol: 23Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.14230Best OA location URL: https://doi.org/10.1111/acel.14230Citation Count: 4
- Synchronous Measurements of Extracellular Action Potentials and Neurochemical Activity with Carbon Fiber Electrodes in Nonhuman Primates2024OPENTitle: Synchronous Measurements of Extracellular Action Potentials and Neurochemical Activity with Carbon Fiber Electrodes in Nonhuman PrimatesJournal Name: eneuroPublisher: Society for NeuroscienceVol: 11Issue #: 7Start Page: ENEURO.0001End Page: 24.2024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-sa, cc-byDOI - Digital Object Identifier: 10.1523/eneuro.0001-24.2024Best OA location URL: https://doi.org/10.1523/eneuro.0001-24.2024Citation Count: 4
-
OPENTitle: A framework to standardize gait study protocols in Parkinson's diseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/1877718x241305626Best OA location URL: https://doi.org/10.1177/1877718x241305626Citation Count: 4
- Spatial genomics of AAV vectors reveals mechanism of transcriptional crosstalk that enables targeted delivery of large genetic cargo2025OPENTitle: Spatial genomics of AAV vectors reveals mechanism of transcriptional crosstalk that enables targeted delivery of large genetic cargoJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41587-025-02565-4Best OA location URL: https://doi.org/10.1038/s41587-025-02565-4Citation Count: 7
-
OPENTitle: LRP1: a novel receptor for the transmission of pathological α-SynucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00582-4Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-022-00582-4Citation Count: 4
-
OPENTitle: Bach1 derepression is neuroprotective in a mouse model of Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 118Issue #: 45Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2111643118Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8694049Citation Count: 65
-
OPENTitle: Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 23Issue #:Start Page: 101824End Page: 101824Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101824Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101824Citation Count: 59
-
OPENTitle: Multimodal assessment of mitochondrial function in Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 1Start Page: 267End Page: 280Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awad364Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad364/54040745/awad364.pdfCitation Count: 23
-
OPENTitle: Deep Learning for Fluorescence Lifetime Predictions Enables High-Throughput In Vivo ImagingJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 147Issue #: 26Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/jacs.5c03749Best OA location URL: https://doi.org/10.1021/jacs.5c03749Citation Count: 0
- Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites2021OPENTitle: Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolitesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 141Issue #: 5Start Page: 725End Page: 754Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-021-02285-4Best OA location URL: https://doi.org/10.1007/s00401-021-02285-4Citation Count: 48
-
OPENTitle: Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non‐Ashkenazi Jewish ancestryJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1432End Page: 1438Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27059Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5656509Citation Count: 151
-
OPENTitle: Association study of essential tremor genetic loci in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 66Issue #:Start Page: 178.e13End Page: 178.e15Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.01.001Best OA location URL: https://zenodo.org/record/3911337Citation Count: 9
- NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation2022OPENTitle: NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome ActivationJournal Name: International Journal of InflammationPublisher: WileyVol: 2022Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/2337363Best OA location URL: https://downloads.hindawi.com/journals/iji/2022/2337363.pdfCitation Count: 8
- Post‐Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 Delivery2023OPENTitle: Post‐Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 DeliveryJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 9Start Page: 1728End Page: 1736Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29518Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29518Citation Count: 15
-
OPENTitle: Lrrk2 p.Q1111H substitution and Parkinson’s disease in Latin AmericaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 17Issue #: 8Start Page: 629End Page: 631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2011.05.003Best OA location URL: https://repositorio.uchile.cl/handle/2250/165323Citation Count: 17
- Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetes2022OPENTitle: Association between different diabetes medication classes and risk of Parkinson's disease in people with diabetesJournal Name: Pharmacoepidemiology and Drug SafetyPublisher: WileyVol: 31Issue #: 8Start Page: 875End Page: 882Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pds.5448Best OA location URL: https://doi.org/10.1002/pds.5448Citation Count: 14
- Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning2021OPENTitle: Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learningJournal Name: The Lancet Digital HealthPublisher: Elsevier BVVol: 3Issue #: 9Start Page: e555End Page: e564Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s2589-7500(21)00101-1Best OA location URL: http://www.thelancet.com/article/S2589750021001011/pdfCitation Count: 62